🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

How do clinicians determine when to initiate cytoreductive treatment in patients with #MPNs, particularly when distinguishing between high-risk and low-risk patients? Hear from Sara Meyer, Claire Harrison and Gabriela Baerlocher on this topic plus more ⬇️

Please join Patrick Forde at our next session on the latest from ASCO for immunotherapies in resectable #NSCLC! He'll be joined by Solange Peters and Jordi Remon to debate IO in early stage & discuss combinations in advanced #NSCLC. ⏰ 25 June at 5.30PM CEST Register now ⬇️

Registration opens on 1 June for the 7th International Lung Cancer Summit #ILCS25! Join our hosts, Alfredo Addeo MD & Solange Peters, and leading experts from around the world to explore the latest breakthroughs in thoracic oncology 🫁 🗓️ 26 September 2025 from 9:30AM CEST

Registration is now open for the 7th International Lung Cancer Summit #ILCS25! Connect with our hosts, Alfredo Addeo MD & Solange Peters, and leading experts to get the latest developments in thoracic oncology 🫁 🗓️ 26 September from 9:30AM CEST ⬇️ Secure your seat early

How do we maximize outcomes with IO combinations in #NSCLC? Join Solange Peters as she discusses the latest evidence and open questions in IO combinations, incl. IO-IO together with Patrick Forde and Jordi Remon. ⏰ 25 June 2025, 5:30PM CEST Check in and attend for free ⬇️

How do we proceed following ASCO with IO in early-stage #NSCLC? 🫁 Don’t miss the live debate with Patrick Forde and Jordi Remon as they discuss the optimal strategies and challenges in IO together with Solange Peters ⏰ 25ᵗʰ June at 5:30PM CEST Join the debate for free ⬇️

Meet this year's global faculty behind the #ILCS! 🌍 From the US to Singapore, Europe to Australia – leading experts will share key insights with our chairs Alfredo Addeo MD and Solange Peters on 26ᵗʰ September in Switzerland and live online. Insights from leaders in lung cancer 🫁

Still unsure how to optimize IO in resectable #NSCLC? 🫁 Join Jordi Remon as he tackles unanswered questions, alongside Solange Peters and Patrick Forde during their debate on IO in early-stage lung cancer. #Immunotherapy ⏰ 25ᵗʰ June at 5:30PM CEST ✅ CME-certified

How do leading thoracic oncologists address the challenges of #SCLC in both limited- and extensive-stage disease? Join Jacob sands together with Solange Peters and Giannis Mountzios exploring the latest clinical developments in #SCLC ⏰ 17ᵗʰ June at 5PM CEST ✅ CME-certified ⬇️

Got an #NSCLC case or a question on immunotherapy? Share it anonymously and get expert input during our upcoming session with Solange Peters, Jordi Remon, and Patrick Forde. #LCSM ⏰ 25ᵗʰ June at 5:30PM CEST 📩 Submit now to be part of the live discussion ⬇️

🚨 TODAY Don't miss today's roundtable on the latest progress in treating small cell lung cancer with renowned experts, Solange Peters, Giannis Mountzios and Jacob sands! #ASCO25 #LCSM ⏰ 17ᵗʰ June at 5PM CEST Tune in for free ⬇️

Two checkpoint inhibitors in #SCLC got approved in Europe based on data from Asian populations only. Does it matter and which ICI should we use? See Giannis Mountzios sharing his take. Watch the full roundtable with more highlights together with Solange Peters & Jacob sands now ⬇️

🔔 Save the Date! Join our faculty Oliver Gautschi, Jarushka Naidoo and Nicolas Girard for a focused update on targeted therapies in #NSCLC. Don’t miss what’s SoC and what's next in precision oncology. #LCSM 📆 Add to your calendar: 10ᵗʰ July at 5PM CEST ✅ CME-certified

Our chair Oliver Gautschi opens the roundtable with an expert analysis of ALK+ and EGFR+ NSCLC. Together with Jarushka Naidoo and Nicolas Girard, he will explore how to tailor treatment across disease stages. #LCSM ⏰ 10ᵗʰ July at 5PM CEST ✅ CME-certified Share your thoughts ⬇️

On our next roundtable Jarushka Naidoo focuses on synergy in EGFR+ NSCLC by highlighting latest combination strategies with chemotherapy, bispecific antibodies and TKIs. She'll be joined by Oliver Gautschi and Nicolas Girard. #LCSM ⏰ 10ᵗʰ July 2025 at 5PM CEST Attend for free ⬇️

📢 We're excited to welcome you today at 5:30 PM CEST for a deep dive into IO in #NSCLC. Solange Peters, Patrick Forde & Jordi Remon will debate neoadjuvant vs. perioperative IO, explore dual IO strategies, share practical insights, and discuss key data from #ASCO25. #LCSM

What’s the role of anti-CTLA-4 in #NSCLC patients with brain metastases? Hear Jordi Remon share his current approach and future outlook with Solange Peters & Patrick Forde. Watch the full roundtable on demand ⬇️

How close are we to using SCLC subtypes to guide treatment? Jacob sands explains why subtyping is still experimental, but promising, for future therapies. Hear on the topic plus much more with Solange Peters & Giannis Mountzios. Watch the full roundtable here ⬇️

Join Oliver Gautschi for an expert-led talk on evolving targeted therapies in NSCLC. Explore ALK+ & EGFR+ challenges, resistance in EGFR mutations & novel combos with TKIs, chemo & more – featuring Jarushka Naidoo & Nicolas Girard ⏰ 10ᵗʰ July 2025 at 5PM CEST ✅ CME-certified

Have a patient case in NSCLC? Submit your case or questions to our experts Oliver Gautschi, Jarushka Naidoo, and Nicolas Girard during the live roundtable. Your question could help shape the discussion and offer clarity to colleagues worldwide. Submit your case below ⬇️